85
65
Growth Score
-2 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
464478
Aviana Molecular Technologies (AMT) is a development stage diagnostic company.
- Paul Sansone: CFO
Vanaja Ragavan: President and CEO
About the Company
Aviana Molecular Technologies (AMT) is a development stage diagnostic company working on an innovative, highly sensitive, and user friendly platform technology, with an initial interest in developing a point of care diagnostic of infections (POC). AMT believes that its technology can detect specific infections within 15 to 20 minutes and can do so
by a non-lab trained health care professional. Such rapid and efficient diagnosis of infections can help in treatment and spread of diseases.
AMT’s technology is simple, adaptable, and can be useful reducing the spread of infections. Conceptually, it can be developed to be used in both highly sophisticated health systems but also in resource-limited environments.
